Trial Profile
A first in man,randomised,double blind,placebo controlled study to evaluate the safety,tolerability and pharmacokinetics of CR6086 in single ascending doses in healthy volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 08 Feb 2017
Price :
$35
*
At a glance
- Drugs CR 6086 (Primary)
- Indications Rheumatoid arthritis
- Focus Adverse reactions; First in man; Pharmacokinetics
- 08 Feb 2017 New trial record